FDA approves shire's treatment of chronic isophation of Motegroity
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
CIC is a very common disease, the main symptoms are long-term defecation difficulties and infrequent, other symptoms include abdominal pain and bloatingrecently, the U.SFDA(http://announced that it has approved the listing of Shirehttp://the treatment of chronic isophalsis (CIC) Motegro, a companyIt is also the 56thnew drug(http://approved by the FDA this yearPrucaloprideShire is a high affinity, specific 5-HT4 receptor agonistIt is a gastrointestinal agent that stimulates colon peristalsis and speeds up feces movementPrucalopride has been tested in more than 90 clinicaltrial
series (http:// worldwide over the past 20 years It has been approved for listing in EU countries This is the first FDA-approved 5-HT4 receptor agonist to treat CIC FDA approval for prucalopride is based on the results of five Phase 3 clinical trials and one Phase 4 double-blind, placebo-controlled clinical trial In these six clinical trials, a total of 2,484 patients were used to assess the efficacy of prucalopride results showed that the proportion of patients taking prucalopride successfully completing three or more full bowel seist sits on their own per week was significantly higher than that of the control group (27.8% vs 13.2%, p0.001 ).
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
